DOCSLIB.ORG

DEPRESSION: Mind and Body Advances in the Understanding and Treatment of Depression and Its Physical Symptoms

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DEPRESSION: Mind and Body Advances in the Understanding and Treatment of Depression and Its Physical Symptoms R7420_2_DEP2_4_COV_CME_03.qxd 20/7/06 17:23 Page 1 VOLUME 2 NUMBER 4 2006 DEPRESSION: Mind and Body Advances in the Understanding and Treatment of Depression and its Physical Symptoms Editor-in-Chief Alan F Schatzberg, Stanford, CA, USA The Role of Vagus Nerve Stimulation as a Therapy for Treatment-Resistant Depression Mustafa M Husain, Kenneth Trevino, Louis A Whitworth, and Shawn M McClintock Neuropsychiatric Effects of IL-2: Mechanisms and Treatment Implications Stephen E Nicolson, Andrew H Miller, David Lawson, and Dominique L Musselman The Bidirectional Relationship between Diabetes Mellitus and Depression Sanjay J Mathew and Susan Burd www.depressionmindbody.com This activity has been planned and implemented in accordance with the Essential Areas and Policies of the ACCME through the joint sponsorship of the University of Kentucky College of Medicine and Remedica. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Kentucky is an equal opportunity university. R7420_2_DEP2_4_COV_CME_03.qxd 20/7/06 17:23 Page 2 Depression: Mind and Body is supported by an unrestricted educational grant from Wyeth Pharmaceuticals Editor-in-Chief Alan F Schatzberg Kenneth T Norris Jr, Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA Editorial Advisory Board Dwight Evans Kurt Kroenke Professor and Chair, Department of Psychiatry, Professor of Medicine, Department of Medicine University of Pennsylvania, Philadelphia, PA, USA and Regenstrief Institute for Health Care, Indiana Maurizio Fava University School of Medicine, Indianapolis, IN, USA Psychiatrist and Director, Depression Clinical and Yves Lecrubier Research Program, Massachusetts General Hospital, Director of Research, Hôpital de la Salpêtrière, Boston, MA, USA Paris, France John Greden Norman Sartorius Professor and Chair, Department of Psychiatry, Psychiatry Department Director, University Hospital, University of Michigan Depression Center, Geneva, Switzerland Ann Arbor, MI, USA Donna Stewart Wayne Katon Professor and Chair, Women’s Health University Professor and Vice Chair, Department of Psychiatry Health Network and University of Toronto, and Behavioral Sciences, University of Washington, Toronto, ON, Canada Seattle, WA, USA Editors Christos Ballas Po W Wang Assistant Clinical Professor, Department of Psychiatry, Senior Research Scientist, Bipolar Disorders Clinic, University of Pennsylvania Medical Center, Philadelphia, Department of Psychiatry and Behavioral Sciences, PA, USA Stanford University School of Medicine, Stanford, CA, USA Editorial Policy Depression: Mind and Body is an independent journal published by Remedica Medical Education and Publishing. Editorial control is the sole responsibility of the Editor-in-Chief, Editorial Advisory Board, and the Editors. Before publication, all material submitted to the journal is subjected to rigorous review by the Editor-in-Chief, Editorial Advisory Board, Editors, and/or independent reviewers for suitability of scientific content, scientific accuracy, scientific quality, and conflict of interest. Aims and Scope Depression: Mind and Body is designed to bring a critical analysis of the world literature on depression, written by clinicians, for clinicians, to an international, multidisciplinary audience. Our mission is to promote better understanding of the treatment of depression across the global healthcare system by providing an active forum for the discussion of clinical and healthcare issues. Leading Articles - These major review articles are chosen to reflect topical clinical and healthcare policy issues in depression. All contributions undergo a strict editorial review process. Clinical Reviews - The most important papers from the best of the international literature on depression are systematically selected by an internationally recognized panel of experts. The Editors then prepare concise and critical analyses of each paper, and, most importantly, place the findings into clinical context. Meeting Reports - Depression: Mind and Body also provides incisive reportage from the most important international congresses. Publisher’s Statement ©2006 Remedica Medical Education and Publishing. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. Depression: Mind and Body (ISSN 1479-5035) is published four times a year by Remedica Publishing Ltd and distributed by USA Mail Agent Pronto Mailers Association, 544 Lincoln Boulevard, Middlesex, NJ 08846. Subscription price $170 per year. Periodicals Postage Paid at Middlesex NJ. POSTMASTER: Please send address changes to Remedica Publishing Ltd, 544 Lincoln Boulevard, Middlesex NJ 08846-2439. Remedica Medical Education and Publishing Ltd., Commonwealth House, 1 New Oxford Street, London WC1A 1NU, UK. Telephone: +44 (0)20 7759 2999 Fax: +44 (0)20 7759 2951 Email: [email protected] Editorial Team: Emma Beagley, Scott Millar Editorial Director: Reghu Venkatesan Publishers: Ian Ackland-Snow, Simon Kirsch Design and Artwork: AS&K Skylight Creative Services ISSN 1479-5035 R7420_2_REM_DEP2_4_17.qxd 20/7/06 17:39 Page 113 Dear Colleagues, Contents Welcome to the final issue of the second volume of Depression: Mind and Body. Leading Articles Although great advances have been made in therapies for The Role of Vagus Nerve Stimulation as a the treatment of depression, some patients fail to respond Therapy for Treatment-Resistant Depression to initial treatment courses, and many do not respond to Mustafa M Husain, Kenneth Trevino, multiple medication trials. These patients are described as Louis A Whitworth, and Shawn M McClintock 114 having treatment-resistant depression (TRD) and the prevalence of this disorder calls for new treatment techniques. In this Neuropsychiatric Effects of IL-2: issue, Dr Husain and colleagues (University of Texas Mechanisms and Treatment Implications Southwestern Medical Center at Dallas, Dallas, TX, USA) Stephen E Nicolson, Andrew H Miller, David Lawson, and Dominique L Musselman 120 discuss a novel neurostimulation technique, vagus nerve stimulation (VNS) therapy, and its role as an antidepressant The Bidirectional Relationship between therapy for patients with TRD. Studies have demonstrated Diabetes Mellitus and Depression the safety and efficacy of VNS therapy for patients suffering Sanjay J Mathew and Susan Burd 130 from TRD, and this article expands upon its mechanism of action and the results of recent trials. Our second article examines interleukin-2 (IL-2), a vital Clinical Reviews signaling molecule in immune and inflammatory responses as Epidemiology 134 well as in cell migration and differentiation. IL-2 has been used for the treatment of diseases such as cancer and AIDS; Clinical Practice 137 however, it exhibits strong adverse effects, including a high Comorbidities 140 incidence of depressive symptoms and memory disturbances. The mechanisms for these effects are not well documented Pathogenesis 142 or understood and Dr Nicolson and colleagues (Emory University School of Medicine, Atlanta, GA, USA) provide an insight into the neuropsychiatric effects of IL-2 and their Meeting Reports treatment implications. 14th Annual Meeting of the Association As is well-known, depression is frequently comorbid with a of European Psychiatrists (AEP) number of diseases. Drs Mathew and Burd (Mount Sinai Nice, France, 4–8 March, 2006 146 School of Medicine, New York, NY, USA) elaborate on the association between depression and diabetes, offering 159th Annual Meeting of the American Psychiatric Association (APA) pathophysiological hypotheses regarding this relationship and Toronto, ON, Canada, 20–25 May, 2006 148 reviewing treatment approaches for the depressed patient suffering from comorbid diabetes mellitus. As in all issues, the Clinical Reviews provide concise and critical analyses of the latest depression literature, placing recent developments into a clinical context. These are followed by reports of the most important presentations concerning depression from the Annual Meeting of the Association of European Psychiatrists (Nice, France) and an extended report of the highlights of the American Psychiatric Association Annual Meeting (Toronto, ON, Canada). We are pleased that the comments we have received about Depression: Mind and Body have been overwhelmingly positive and that the journal continues to be regarded as a useful resource by clinicians working in this fast-developing field. We welcome your comments and suggestions and look forward to your feedback and any thoughts to help us provide a relevant review of current topics.
Load more

Recommended publications
  • I Harry Shapiro & Ann 3947 831 II II John R
    #1 FROM BOOK GRAN'.fOR GRANTEE Book Page Jan 2 Sec, of H. & U.D. Mathias W. Guthrie & Nancy C. 3947 854 • II II II 3947 II II II 3947 II II ::: I Harry Shapiro & Ann 3947 831 II II John R. Siegel & Caroll A, 3947 965 II II Harry Shapiro & Ann 3947 909 I II II Anderson Williamson & Curlie Mae 3947 902 j II Schiedrich, Delores et al Noel E. Wynne, Jr., et al 3947 866 l ,! II Sentinel Realty Co., franklin D. JOnes & Betty 3947 858 ij II Schaefer, Portia F. Ben Schaefer Buildigg, Co., 3947 815 l II I I Straehley, Jr., Erwin (Dec'd) Cert of Tr Margaret C. Straeh l ey 3947 967 II Schnurr, Jr., Goerog L.et al William Arnold Breig & Janice C, 3947 953 I II Scott, Pete et al City of Cincinnati 3947 948. ~ II S to 11 , Lo i s 8 • Donald E. Julian & Mildred E. 3947 919 ~ II Stagge, Mary Agnes Bernard James Stagge 3947 I 899 ~ !1 II Schneider, Josef et a 1 Ferdinand A. Fo~ney, Trustee 3947 t 969 ril 3 Scott, Shelby (Dec'd) Cert of Tr. Edna Scott 3948 t • 74. JI II Sec, of H. & U.D. Ray Mjracle & Earleen M. 1• 3948 I 72 11 II 11 I 1 11 Ca r 1 J • Pa r ks 3948 l 211 Ji tl II 1 1 Mathias W. Guthrie & Nancy C. 157 1 ·~ 3948 1 !: II II II 3948 177. # ii II II I Carl J. Parks 3948 1 52 H ft II Scott, Robert 8, ii Betty Jo Scott 3948 92 j! II & Ji I Sec.
    [Show full text]
  • Name Lebensdaten SS SM, Rosi
    Name Lebensdaten Archivalien (Zeichen ≙ DSK-Sign. => MATERIALIEN) S S S. M., Rosi -MuM,D,Fi 19.. D 1.441,770 S., Anita -NaM 1895 D K1054 S., Ekatherina 19.. ART4.3-9 S., Johanna 19.. ART4.2 SA SA SA, Rosilda 19.. DS7 SA, Rosilda i335 SAAB, Jocelyne -Fi 1948 RL 1.411,779 SAAB, Jocelyne -Fi i3275 SAABYE, Mette -Ks 1969 DK K1430,1492 SAABYE, Susanne 1856-1939 DK Bu SAADE, Stephanie -I 1983 RL/F Be101,105,106 SAADEH, Raeda -P,F 1977 PS 6.144 SAADEH, Raeda -P,F Be39,41,42 SAADEH, Raeda -P,F i,i1289 SAADEH, Raeda -P,F K863,1062 SAADI, Hana al -P 19.. Q i6505 SAAD-SKOLNIK, Sabina -M 1950 I/IL 4.57.3 SAAGE, Carolin -F 1978 D i6636 SAAL, Linda Rosa -F 1985 D Be92 SAAL, Linda Rosa -F K1666 SAAL, Ulrike -Gl 1953 D K450 SAALFELD, Christine -G,NM,I 1968 D/NL Be59,61 SAALFELD, Katharina von -W 19.. F Be99 SAALFRANK, Gudrun 19.. K60 SAALMANN, Karin -B,M 1938-2005 D K2349 SAAM, Karin -G 1950 D K318,319 SAAMAN, Karen 19.. NL K1329.5 SAAR, Alison -O 1956 USA 1.253,423 SAAR, Alison -O Be110-113,115 SAAR, Betye -O 1926 USA 1.24,25,321,423,583 SAAR, Betye -O Be106,107,112-115 SAAR, Betye -O i (DK), SAAR, Betye -O P120 SAAR, Gabriele -M 1960 K1093,1094 SAAR, Katja -D 1984 D i3551,4761,4790 SAAR, Lezley -S 1953 USA 1.423 SAARBOURG, Irmtrud 1936 D KFBW SAARE, Mare -Kg 1965 EST Be71,82,86 SAARE, Mare -Kg i4795 SAARHELO, Sanna 19.
    [Show full text]
  • Sackler Faculty of Medicine Clinical
    Sackler Faculty of Medicine Clinical Research 2017 בעקבות הלא נודע בעקבות הלא נודע Sections Cancer 6 Cardiovascular System 45 Digestive System 72 Endocrine Disease 88 Genetic Diseases & Genomics 107 Immunology & Hematology 127 Infectious Diseases 133 Neurological & Psychiatric Diseases 144 Ophthalmology 181 Public Health 187 Reproduction 198 Stem Cells & Regenerative Medicine 205 Cover images (from bottom left, clockwise): Image 1: Staining of a novel anti-frizzled7 monoclonal antibody directed at tumor stem Cells. Credit: Benjamin Dekel lab. Image 2: Growing adult kidney spheroids and organoids for cell therapy. Credit: Benjamin Dekel lab. Image 3 & 4: Vibrio proteolyticus bacteria infecting macrophages. Credit: Dor Salomon. Image 5: K562 leukemia cells responding to complement attack (red-complement C9, green-mitochondrial stress protein mortalin) Credit: Niv Mazkereth, Zvi Fishelson. Image 6: Cardiomyocyte proliferation in newborn mouse heart by phosphohistone 3 staining (purple). Credit: Jonathan Leor. © All rights reserved Editor: Prof. Karen Avraham Graphic design: Michal Semo Kovetz, TAU Graphic Design Studio June 2017 Sackler Faculty of Medicine Research 2017 2 בעקבות הלא נודע The Sackler Faculty of Medicine The Sackler Faculty of Medicine is Israel’s largest diabetes, neurodegenerative diseases, infectious medical research and training complex. The Sackler diseases and genetic diseases, including but not Faculty of Medicine of Tel Aviv University (TAU) was imited to Alzheimer’s disease, Parkinson’s disease founded in 1964 following the generous contributions and HIV/AIDS. Physicians in 181 Sacker affiliated of renowned U.S. doctors and philanthropists departments and institutes in 17 hospitals hold Raymond, and the late Mortimer and Arthur Sackler. academic appointments at TAU. The Gitter-Smolarz Research at the Sackler Faculty of Medicine is Life Sciences and Medicine Library serves students multidisciplinary, as scientists and clinicians combine and staff and is the center of a consortium of 15 efforts in basic and translational research.
    [Show full text]
  • Towards a Unifying, Systems Biology Understanding Of
    Arch Toxicol (2010) 84:825–889 DOI 10.1007/s00204-010-0577-x REVIEW ARTICLE Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples Douglas B. Kell Received: 14 June 2010 / Accepted: 14 July 2010 / Published online: 17 August 2010 Ó The Author(s) 2010. This article is published with open access at Springerlink.com Abstract Exposure to a variety of toxins and/or infec- means that multiple interventions (e.g. of iron chelators tious agents leads to disease, degeneration and death, often plus antioxidants) are likely to prove most effective. A characterised by circumstances in which cells or tissues do variety of systems biology approaches, that I summarise, not merely die and cease to function but may be more or can predict both the mechanisms involved in these cell less entirely obliterated. It is then legitimate to ask the death pathways and the optimal sites of action for nutri- question as to whether, despite the many kinds of agent tional or pharmacological interventions. involved, there may be at least some unifying mechanisms of such cell death and destruction. I summarise the evi- Keywords Antioxidants Á Apoptosis Á Atherosclerosis Á dence that in a great many cases, one underlying mecha- Cell death Á Chelation Á Chemical toxicology Á Iron Á nism, providing major stresses of this type, entails Neurodegeneration Á Phlebotomy Á Polyphenols Á Sepsis Á continuing and autocatalytic production (based on positive SIRS Á Stroke Á Systems biology Á Toxicity feedback mechanisms) of hydroxyl radicals via Fenton chemistry involving poorly liganded iron, leading to cell Abbreviations death via apoptosis (probably including via pathways Abb-amyloid induced by changes in the NF-jB system).
    [Show full text]
  • Resultado Preliminar Da 1ª Fase – Prova Objetiva
    ORDEM DOS ADVOGADOS DO BRASIL CONSELHO FEDERAL DA ORDEM DOS ADVOGADOS DO BRASIL XX EXAME DE ORDEM UNIFICADO RESULTADO PRELIMINAR DA 1ª FASE – PROVA OBJETIVA O Conselho Federal da Ordem dos Advogados do Brasil (OAB) torna público o resultado preliminar da 1ª fase (prova objetiva) do XX Exame de Ordem Unificado. I - Relação dos examinandos aprovados na prova objetiva, na seguinte ordem: seccional, cidade de prova, número de inscrição e nome do examinando em ordem alfabética. 1. OAB / AC 1.1. RIO BRANCO 716009323, Adriano Santos Leao / 716051007, Aila Freitas Pires / 716134662, Alexson Bussons Miranda / 716081076, Aline Ramalho De Sousa Cordeiro / 716083631, Aline Rariane Parente Da Silva / 716134440, Alyne Lopes Da Silva / 716002371, Ana Beatriz Da Silva Barbosa / 716037084, Ana Cleide Lima Da Silva / 716113942, Ana Flávia Rufino De Moura / 716113854, André Arruda De Souza Derze / 716014037, Andréia Cristina Rufino De Moura / 716120971, Annayara Vidal De Sá / 716019285, Antonia Keldiney Gomes De Sousa / 716076256, Antonia Patrícia Da Silva Cardoso / 716083425, Antonio Alberto De Menezes / 716108793, Bárbara Maués Freire / 716115632, Benildson Leite De Oliveira / 716114564, Bruna Do Sacramento Medina / 716113003, Caio Lima Carvalho / 716068379, Camila Beatriz Gondim Da Silva / 716071529, Carlos César Pinheiro Bastos / 716033757, Carlos Eduardo Feital Nogueira / 716096623, Carolina Carvalho De Souza / 716096737, Carolina Dos Santos Miranda / 716150957, Cid Natal Da Silva Ramos / 716052961, Clediane Santana Barbosa / 716084304, Creuza Dantas
    [Show full text]
  • The Role of Prolactin in the Cellular Response to DNA Damaging Agents
    University of Calgary PRISM: University of Calgary's Digital Repository Graduate Studies The Vault: Electronic Theses and Dissertations 2015-09-30 The Role of Prolactin in the Cellular Response to DNA Damaging Agents Karayazi Atici, Odul Karayazi Atici, O. (2015). The Role of Prolactin in the Cellular Response to DNA Damaging Agents (Unpublished doctoral thesis). University of Calgary, Calgary, AB. doi:10.11575/PRISM/28347 http://hdl.handle.net/11023/2567 doctoral thesis University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. Downloaded from PRISM: https://prism.ucalgary.ca UNIVERSITY OF CALGARY The Role of Prolactin in the Cellular Response to DNA Damaging Agents by Odul Karayazi Atici A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN BIOLOGICAL SCIENCES CALGARY, ALBERTA SEPTEMBER, 2015 © Odul Karayazi Atici 2015 Abstract High serum levels of the peptide hormone prolactin are associated with increased breast cancer risk and poor prognosis. Prolactin is also involved in breast cancer resistance to different chemotherapeutics. The overall goal of this project is to investigate potential pathways involved in prolactin induced resistance to DNA damaging agents with the hypothesis that the cross-talk between the prolactin pathway and the DNA damage response is important in the mechanism.
    [Show full text]
  • Dissertation Final (Shuang Liang)
    NEW APPROACH TO DNA TRANSFECTION AND GENETICS IN SCHISTOSOME PARASITES By SHUANG LIANG Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Thesis Advisor: Dr. Emmitt R. Jolly Department of Biology CASE WESTERN RESERVE UNIVERSITY May 2015 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of Shuang Liang candidate for the degree of Doctor of Philosophy*. Committee Chair Hillel J. Chiel Committee Member Emmitt R. Jolly Committee Member Brian M. McDermott Committee Member Claudia Mizutani Committee Member Pieter L. deHaseth *We also certify that written approval has been obtained for any proprietary material contained therein. Copyright©2015 by Shuang Liang All rights reserved ii Thesis Outline Acknowledgements Table of contents Abstract Chapter 1: Introduction and significance Chapter 2: Polyethyleneimine mediated DNA transfection in schistosome parasites and regulation of the WNT signaling pathway by a dominant-negative SmMef2 Chapter 3: Evaluation of schistosome promoter expression for transgenesis and genetic analysis Chapter 4: Discussions and future directions Appendix: Molecular cloning and characterization of Hsp90 in the crayfish P. clarkii Bibliography i Acknowledgements This is a wide spread picture on the Internet drawn by a professor from University of Utah. The figure illustrates exactly how a tiny breakthrough off the boundary of the circle from a Ph.D. project contributes to the world. During my six-year school life at Case Western Reserve University, my thesis advisor Dr. Emmitt Jolly set a role model to keep reminding me how to push further from the boundary you are focused on as well as keep your eyes open to the whole universe.
    [Show full text]
  • 1056 T CELLS and AGING, JANUARY 2002 UPDATE Graham
    [Frontiers in Bioscience 7, d1056-1183, May 1, 2002] T CELLS AND AGING, JANUARY 2002 UPDATE Graham Pawelec1, Yvonne Barnett2, Ros Forsey3, Daniela Frasca4, Amiela Globerson5, Julie McLeod6, Calogero Caruso7, Claudio Franceschi8, Támás Fülöp9, Sudhir Gupta10, Erminia Mariani8, Eugenio Mocchegiani11, Rafael Solana12 1University of Tübingen, Center for Medical Research, ZMF, Waldhörnlestr. 22, D-72072 Tübingen, Germany, 2 University of Ulster, Coleraine, UK, 3 Unilever Research, Bedford, UK, 4 University of Miami, FL, 5 University of the Negev, Israel, 6 University of the West of England, Bristol, UK, 7 University of Palermo, Italy, 8 University of Bologna, Italy, 9 University of Sherbrooke, Quebec, Canada, 10 University of California, Irvine, CA, 11 INRCA, Ancona, Italy, 12 University of Córdoba, Spain TABLE OF CONTENTS 1. Abstract 2. Introduction: How do we establish whether immunosenescence exists and if so whether it means anything to immunological defence mechanisms in aging? 3. Factors contributing to immunosenescence 3.1. Hematopoiesis 3.2. Thymus 4. Post-thymic aging 4.1. T cell subsets 4.2. T cell repertoire 4.3. T cell function 4.3.1. Accessory cells 4.3.2. T cell receptor signal transduction 4.3.3. Costimulatory pathways 4.3.3.1. CD28 family coreceptors and CD80 family ligands 4.3.3.2. Other costimulators 4.4. Cytokine production and response 4.4.1. Regulation of gene transcription 4.4.2. Cytokine secretion 4.4.3. Confounding factors affecting cytokine secretion results 4.4.4. Levels of cytokines in plasma 4.4.5. Cytokine antagonists 4.4.6. Cytokine receptor expression 5. Clonal expansion after T cell activation 5.1.
    [Show full text]
  • RESULTADO FINAL DE APROVADOS a CONSULPLAN, No Uso Das Atribuições Concedidas Pelo Edital N.º 02 De 2019, Que Normatiza O Exam
    RESULTADO FINAL DE APROVADOS A CONSULPLAN, no uso das atribuições concedidas pelo Edital N.º 02 de 2019, que normatiza o Exame de Suficiência para Obtenção do Registro profissional em Conselho Regional de Contabilidade, TORNA PÚBLICO o Resultado Final, publicado no Diário Oficial da União Seção 3, páginas 176 a 198, bem como o resultado dos recursos interpostos contra o resultado preliminar da prova objetiva. Os examinandos que interpuseram recurso contra o resultado preliminar da prova objetiva terão acesso a decisão através link de consulta individual publicado no endereço eletrônico www.consulplan.net. Em 4 de dezembro de 2019.
    [Show full text]
  • St. Louis Globe-Democrat Index to Deaths, 1860
    St. Louis Globe-Democrat www.slcl.org Special Collections Department Index to deaths, 1860 - 1861, 1880 [email protected] St. Louis County Library Page 1 Publication Last name First name date Page Year Notes Unknown Alice 16-Jan 10 1883 Burial Permit, Infant , St Ann's Asylum Unknown Bill 6-Jun 11 1883 Burial Permit Unknown Christopher 3-Jan 8 1883 Burial Permits, St Ann's Asylum, infant Yesterdays's Death/ Burial Permit, St Unknown Emmett (Foundling) 8-Nov 12 1883 Ann's Asylum Unknown Francis 3-Jan-12 8 1883 Burial Permits, St. Ann's Asylum, infant Yesterdays's Death/ Burial Permit, St Unknown Kate (Foundling) 27-Oct 12 1883 Ann's Asylum Yesterdays's Death/ Burial Permit, St Unknown Kate Mary (Foundling 27-Oct 12 1883 Ann's Asylum Unknown Lawrence 3-Jan 8 1883 Burial Permits, St. Ann's Asylum, infant Unknown Sara 6-Jan 12 1883 Burial Permit, St.Ann's Asylum,Infant Unknown Thomas 16-Jan 10 1883 Burial Permit; Infant, St Ann's Asylum Unknown Unknown 6-Jan 12 1883 Burial Permit; about 60 yrs. Old Unknown Unknown (Male Infant) 3-Mar 10 1883 Cases Before the Coroner Unknown Whitehead 27-Feb 5 1883 Drowned in the St. John's River Unknown Bill 2-Jun 6 1883 Local Brevities Unknown (Founding) Margaret Mary 17-Mar 9 1883 Burial Permit, St Ann's Asylum Yesterdays's Death/ Burial Permit, St Unknown (Foundling) Agnes 13-Nov 12 1883 Ann's Asylum Yesterdays's Death/ Burial Permit, St Unknown (Foundling) Alice 3-Oct 3 1883 Ann's Asylum Unknown (Foundling) Anna Maria 5-Aug 9 1883 Burial Permit, St Ann's Asylum Yesterday's Burial Permits, St Ann's Unknown (Foundling) Anthony 24-Nov 12 1883 Asylum Unknown (Foundling) Arthur 4-Jul 8 1883 Burial Permit, St Ann's Asylum Yesterdays's Death List/ Burial Permit, St Unknown (Foundling) Augusta 7-Dec 12 1883 Ann's Asylum St.
    [Show full text]
  • A Lipid-Invasion Model for Alzheimer's Disease
    A lipid-invasion model for Alzheimer’s Disease Jonathan D'Arcy Rudge 1 1 School of Biological Sciences, University of Reading, Reading, Berkshire, United Kingdom Corresponding Author: Jonathan Rudge 1 Email address: [email protected] PeerJ Preprints | https://doi.org/10.7287/peerj.preprints.27811v5 | CC BY 4.0 Open Access | rec: 18 Nov 2019, publ: 18 Nov 2019 Abstract This paper describes a potential new explanation for Alzheimer’s disease (AD), referred to here as the lipid-invasion model. It proposes that AD is primarily caused by the influx of lipids following the breakdown of the blood brain barrier (BBB). The model argues that a principal role of the BBB is to protect the brain from external lipid access. When the BBB is damaged, it allows a mass influx of (mainly albumin-bound) free fatty acids (FFAs) and lipid-rich lipoproteins to the brain, which in turn causes neurodegeneration, amyloidosis, tau tangles and other AD characteristics. The model also argues that, whilst β-amyloid causes neurodegeneration, as is widely argued, its principal role in the disease lies in damaging the BBB. It is the external lipids, entering as a consequence, that are the primary drivers of neurodegeneration in AD., especially FFAs, which induce oxidative stress, stimulate microglia-driven neuroinflammation, and inhibit neurogenesis. Simultaneously, the larger, more lipid-laden lipoproteins, characteristic of the external plasma but not the CNS, cause endosomal-lysosomal abnormalities, amyloidosis and the formation of tau tangles, all characteristic of AD. In most cases (certainly in late-onset, noninherited forms of the disease) amyloidosis and tau tangle formation are consequences of this external lipid invasion, and in many ways more symptomatic of the disease than causative.
    [Show full text]
  • Psychotic Experiences and Subjective Cognitive Complaints Among 224
    Epidemiology and Psychiatric Psychotic experiences and subjective cognitive Sciences complaints among 224 842 people in 48 cambridge.org/eps low- and middle-income countries A. Koyanagi1,2, B. Stubbs3,4,5, E. Lara2,6, N. Veronese7,8, D. Vancampfort9,10, 11 1,2 12 13 Original Article L. Smith , J. M. Haro ,H.Oh and J. E. DeVylder 1 Cite this article: Koyanagi A, Stubbs B, Lara E, Research and Development Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan Veronese N, Vancampfort D, Smith L, Haro JM, de Déu, Barcelona, Spain; 2Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Oh H, DeVylder JE (2020). Psychotic Mental, CIBERSAM, Madrid, Spain; 3Physiotherapy Department, South London and Maudsley NHS Foundation experiences and subjective cognitive Trust, Denmark Hill, London, UK; 4Department of Psychological Medicine, Institute of Psychiatry, Psychology and complaints among 224 842 people in 48 low- Neuroscience, King’s College London, London, UK; 5Faculty of Health, Social Care and Education, Anglia Ruskin and middle-income countries. Epidemiology University, Chelmsford, UK; 6Department of Psychiatry, Universidad Autónoma de Madrid, Madrid, Spain; and Psychiatric Sciences 29,e11,1–11. https:// 7National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy; 8Geriatrics Unit, Department of doi.org/10.1017/S2045796018000744 Geriatric Care, OrthoGeriatrics and Rehabilitation, E.O. Galliera Hospital, National Relevance and High 9 10 Received: 6 August 2018 Specialization
    [Show full text]